STAT3 and metabolic disease: The mechanisms of action of this drug against cancer, bacterial, viral, and metabolic diseases include uncoupling of oxidative phosphorylation and modulation of Wnt/β-catenin, NF-κB, STAT3, mTORC1, and Notch signaling pathways.42